Patents by Inventor Frank L. Greenway

Frank L. Greenway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11058662
    Abstract: The present invention relates to methods of treating overweight or obesity, reducing fat, sugar, and food intake, and reducing body weight or body weight gain in a subject using geranium oil or orlistat mouthwash, or a combination of both.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: July 13, 2021
    Assignee: Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: Hans-Rudolf Berthoud, Frank L. Greenway, Stefany Deprato Primeaux
  • Publication number: 20210177941
    Abstract: The present disclosure provides compositions including an amylin receptor agonist and a beta-2-adreno-receptor agonist (e.g., an anti-hyperglycemia agent), compositions including at least two different anti-catabolic agents, compositions including at least two different anti-adiposity agents, methods of treating a condition (e.g., muscle wasting, muscle wasting-related condition, excess adiposity, an excess adiposity-related condition, and the like), methods of increasing muscle mass, formation of thermogenic brown adipose tissue (BAT), and/or decreasing white adipose tissue (WAT) content, methods of treating muscle wasting, methods of treating excess adiposity, and the like.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 17, 2021
    Inventors: Antonio E. Civitarese, Frank L. Greenway
  • Publication number: 20210100268
    Abstract: A method is disclosed for making palatable methionine-restricted foods, to deliver a methionine-restricted diet to human or veterinary patients. A protein or a food product containing protein is partially oxidized, preferably with ozone, to oxidize nearly all of the methionine and cysteine. After oxidation, tryptophan and lysine are optionally added back since they tend to be oxidized also. Optionally, a small amount of methionine is also added back so that the final methionine is within a preferred range of about 0.85 to about 1.8 gram methionine per 100 gram total protein, preferably about 1.2 gram per 100 gram total protein.
    Type: Application
    Filed: December 16, 2020
    Publication date: April 8, 2021
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: John W. Finley, Thomas Gettys, Frank L. Greenway
  • Patent number: 10897921
    Abstract: A method is disclosed for making palatable methionine-restricted foods, to deliver a methionine-restricted diet to human or veterinary patients. A protein or a food product containing protein is partially oxidized, preferably with ozone, to oxidize nearly all of the methionine and cysteine. After oxidation, tryptophan and lysine are optionally added back since they tend to be oxidized also. Optionally, a small amount of methionine is also added back so that the final methionine is within a preferred range of about 0.85 to about 1.8 gram methionine per 100 gram total protein, preferably about 1.2 gram per 100 gram total protein.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: January 26, 2021
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: John W. Finley, Thomas Gettys, Frank L. Greenway
  • Publication number: 20200113866
    Abstract: The present invention relates to methods of treating overweight or obesity, reducing fat, sugar, and food intake, and reducing body weight or body weight gain in a subject using geranium oil or orlistat mouthwash, or a combination of both.
    Type: Application
    Filed: December 13, 2019
    Publication date: April 16, 2020
    Inventors: Hans-Rudolf Berthoud, Frank L. Greenway, Stefany DePrato Primeaux
  • Patent number: 10507194
    Abstract: The present invention relates to methods of treating overweight or obesity, reducing fat, sugar, and food intake, and reducing body weight or body weight gain in a subject using geranium oil or orlistat mouthwash, or a combination of both.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: December 17, 2019
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
    Inventors: Frank L. Greenway, Stefany DePrato Primeaux
  • Publication number: 20190008821
    Abstract: The present invention relates to methods of treating overweight or obesity, reducing fat, sugar, and food intake, and reducing body weight or body weight gain in a subject using geranium oil or orlistat mouthwash, or a combination of both.
    Type: Application
    Filed: August 10, 2016
    Publication date: January 10, 2019
    Inventors: Hans-Rudolf BERTHOUD, Frank L. GREENWAY, Stefany DePrato PRIMEAUX
  • Publication number: 20180221449
    Abstract: The present disclosure provides compositions including an amylin receptor agonist and a beta-2-adreno-receptor agonist (e.g., an anti-hyperglycemia agent), compositions including at least two different anti-catabolic agents, compositions including at least two different anti-adiposity agents, methods of treating a condition (e.g., muscle wasting, muscle wasting-related condition, excess adiposity, an excess adiposity-related condition, and the like), methods of increasing muscle mass, formation of thermogenic brown adipose tissue (BAT), and/or decreasing white adipose tissue (WAT) content, methods of treating muscle wasting, methods of treating excess adiposity, and the like.
    Type: Application
    Filed: August 25, 2015
    Publication date: August 9, 2018
    Inventors: Antonio E. CIVITARESE, Frank L. GREENWAY
  • Publication number: 20180055848
    Abstract: A combination of albuterol and caffeine can be used to reduce fat body mass or to increase lean body mass. The combination may be used to treat conditions such as obesity or sarcopenia. There is a substantial synergy in the combinations: The combined effect of albuterol and caffeine is significantly greater than would be expected from the known properties of the individual components.
    Type: Application
    Filed: January 28, 2016
    Publication date: March 1, 2018
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventor: Frank L. Greenway
  • Publication number: 20160128363
    Abstract: A method is disclosed for making palatable methionine-restricted foods, to deliver a methionine-restricted diet to human or veterinary patients. A protein or a food product containing protein is partially oxidized, preferably with ozone, to oxidize nearly all of the methionine and cysteine. After oxidation, tryptophan and lysine are optionally added back since they tend to be oxidized also. Optionally, a small amount of methionine is also added back so that the final methionine is within a preferred range of about 0.85 to about 1.8 gram methionine per 100 gram total protein, preferably about 1.2 gram per 100 gram total protein.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 12, 2016
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: John W. FINLEY, Thomas GETTYS, Frank L. GREENWAY
  • Patent number: 8334000
    Abstract: An extract of Chinese blackberry (Rubus suavissimus) has been found to inhibit angiogenesis, and two active fractions isolated. Gallic acid was shown to be one of the active anti-angiogenic compounds by an in vitro human angiogenesis model. Aqueous extracts from other plants either known or found to have gallic acid were also found to have anti-angiogenic activity. Various derivatives of gallic acid were found to inhibit angiogenesis. The extract from Chinese blackberry also slowed the growth of a pancreatic tumor and of corneal neovascularization in rats. Extracts from pomegranate were shown to inhibit angiogenesis in fat tissue. Extracts from Rubus spp, and other plants with gallic acid, and gallic acid and its derivatives will be useful for treating various diseases associated with neovascularization, including diabetic retinopathy, psoriasis, tumors, obesity, cancer, rheumatoid arthritis, etc.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: December 18, 2012
    Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
    Inventors: Frank L. Greenway, Zhijun Liu, Eugene A. Woltering
  • Publication number: 20120071431
    Abstract: Extracts of radix platycodin are used to inhibit angiogenesis, particularly angiogenesis that is associated with disease conditions other than obesity or cancer.
    Type: Application
    Filed: March 28, 2011
    Publication date: March 22, 2012
    Inventors: Frank L. Greenway, Zhijun Liu
  • Publication number: 20100247434
    Abstract: An extract of Chinese blackberry (Rubus suavissimus) has been found to inhibit angiogenesis, and two active fractions isolated. Gallic acid was shown to be one of the active anti-angiogenic compounds by an in vitro human angiogenesis model. Aqueous extracts from other plants either known or found to have gallic acid were also found to have anti-angiogenic activity. Various derivatives of gallic acid were found to inhibit angiogenesis. The extract from Chinese blackberry also slowed the growth of a pancreatic tumor and of corneal neovascularization in rats. Extracts from pomegranate were shown to inhibit angiogenesis in fat tissue. Extracts from Rubus spp, and other plants with gallic acid, and gallic acid and its derivatives will be useful for treating various diseases associated with neovascularization, including diabetic retinopathy, psoriasis, tumors, obesity, cancer, rheumatoid arthritis, etc.
    Type: Application
    Filed: March 22, 2010
    Publication date: September 30, 2010
    Inventors: Frank L. Greenway, Zhijun Liu, Eugene A. Woltering
  • Patent number: 7709031
    Abstract: An extract of Chinese blackberry (Rubus suavissimus) has been found to inhibit angiogenesis, and two active fractions isolated. Gallic acid was shown to be one of the active anti-angiogenic compounds by an in vitro human angiogenesis model. Aqueous extracts from other plants either known or found to have gallic acid were also found to have anti-angiogenic activity. Various derivatives of gallic acid were found to inhibit angiogenesis. The extract from Chinese blackberry also slowed the growth of a pancreatic tumor and of corneal neovascularization in rats. Extracts from pomegranate were shown to inhibit angiogenesis in fat tissue. Extracts from Rubus spp, and other plants with gallic acid, and gallic acid and its derivatives will be useful for treating various diseases associated with neovascularization, including diabetic retinopathy, psoriasis, tumors, obesity, cancer, rheumatoid arthritis, etc.
    Type: Grant
    Filed: May 27, 2004
    Date of Patent: May 4, 2010
    Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
    Inventors: Frank L. Greenway, Zhijun Liu, Eugene A. Woltering
  • Patent number: 7150141
    Abstract: Presented in one embodiment is a waist chain comprising a plurality of links; a plurality of coupling members which connect the plurality of links, thereby forming a chain with two ends; and at least one end connection member which is connectable to both ends of the chain such that the chain becomes continuous. The waist chain is positioned tightly around the waist of a person such that as the person's weight increases, the waist chain becomes increasingly tight. Presented in another embodiment is a waist chain comprising a plurality of links; a plurality of coupling members which connect the plurality of links, thereby forming a chain with two ends; at least one end connection member which is connectable to both ends of the chain such that the chain becomes continuous and at least one end link which is connectable to one or both ends of the chain and to the end connection member. The end connection member is a hollow cylinder comprising a side wall.
    Type: Grant
    Filed: November 14, 2003
    Date of Patent: December 19, 2006
    Assignee: Board of Supervisors of Louisiana State University Agricultural & Mechanical College
    Inventors: Frank L. Greenway, Andrew T. Roberts
  • Patent number: 6417231
    Abstract: A method and composition are disclosed for administering pyruvate in high doses to mammals, including humans. The method and composition do not produce an excessive acid load, salt load, or nitrogen load. Bioavailability of pyruvate from the composition is high.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: July 9, 2002
    Inventors: Frank L. Greenway, Jennifer C. Rood
  • Patent number: 5952026
    Abstract: A potato chip having no added fat and process for preparation thereof, wherein a slice of undehydrated fresh potato having no added fat and no coating of globular protein and having a thickness of about 1 to about 3 millimeters is heated in a microwave oven at high intensity, with periodic heating separated by periodic cooling for a period of time sufficient to produce a product having essentially the same flavor, color and crispness as potato slices fried in deep fat. The resulting potato chip has substantially reduced calories as compared with potato chips fried in deep fat or oil, and has essentially the same low fat content as uncooked potatoes. Optionally, the slice may be coated with a non-globular protein coating prior to microwave heating. Such a coating may include salt, non-globular protein, flavorants, spices, and/or vitamin additives, as desired, but preferably does not contain any fat which would increase the fat and calorie content of the finished potato chip.
    Type: Grant
    Filed: September 22, 1993
    Date of Patent: September 14, 1999
    Inventors: Frank L. Greenway, George A. Bray
  • Patent number: 4588724
    Abstract: A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.
    Type: Grant
    Filed: January 11, 1985
    Date of Patent: May 13, 1986
    Inventors: Frank L. Greenway, III, George A. Bray
  • Patent number: 4525359
    Abstract: A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.
    Type: Grant
    Filed: December 10, 1982
    Date of Patent: June 25, 1985
    Inventors: Frank L. Greenway, III, George A. Bray